Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden

por Frisk, P., Aggefors, K., Cars, T., Feltelius, N., Loov, S. A., Wettermark, B., Weiland, O.
Publicado 2018